Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens for enhanced protection
2023-06-21
(Press-News.org)
A team of researchers from the Chinese Academy of Sciences, the Chinese Academy of Agricultural Sciences, and Beijing Institute of Pharmacology and Toxicology have made significant progress in developing multi-valent mRNA vaccines against monkeypox virus (MPV), the agent that can cause smallpox-like disease in humans. Their study showed the multi-valent mRNA vaccines with different combinations of monkeypox enveloped viron (EV) or mature viron (MV) surface antigens induced dynamic immune responses with a robust IgG response and correlating neutralizing activities. The vaccines protected a mouse model from a lethal dose vaccinia virus (VACV) challenge.
The study was published online in Science China Life Sciences. It provides insight into the protective mechanism of multi-valent mRNA vaccines and supports the development of effective and safe mRNA vaccines for enhanced protection against monkeypox virus outbreak.
Monkeypox, a virus that causes a disease similar to smallpox in humans, was first identified in African non-human primates in the 1950s. In recent years, the incidence of human-to-human transmission has increased, resulting in an expanding epidemic of monkeypox virus infection that spread to many countries around the world. Monkeypox was declared a global health emergency by the World Health Organization in July 2022.
The researchers first focused on the viral protein targets which are the key for vaccine development. They chose six MPV surface proteins, two from EV (A35R and B6R) and four from MV (A29L, E8L, H3L, and M1R), based on the studies of other orthopoxvirus and assessment of the immunogenicity potential of MPV surface proteins using an in silico computation approach. The multi-valent mRNA vaccines with EV-only, MV-only, or EV+MV combined antigens were administered in Balb/c mice to assess their safety and immunogenicity potentials. A dynamic immune response was observed as soon as seven days after initial immunization, while the antibody responses for all the EV- and MV-surface antigens were significantly boosted with the second immunization.
Researchers also found that the EV+MV combined immunogens contributed to a more robust total IgG response and correlating neutralizing activity against VACV, indicating the additive potential of each immunogen in generating immune response and nullifying VACV infection. Furthermore, the mRNA vaccines were shown to elicit an antigen-specific CD4+ T cell response that is biased towards Th1.
“Amazingly, in a mouse model challenged with a lethal dose VACV, all the mice immunized with the mRNA vaccines (with various combinations of EV and MV surface antigens) survived VACV infection.” explained Dr. Pei Hao, leading researcher of the collaborative study and senior author of the published paper. “Particularly the strongest protection was seen with the EV and MV surface antigens-combined vaccine (MPV-EM6), which shows an excellent correlation with the total IgG response and corresponding neutralizing activity (against VACV). It is a good indication that our multi-valency approach is paying off.”
The swift responsible time and flexibility of mRNA vaccines provide an un-paralleled platform for rapid development and deployment of vaccines against any threat of pathogenic outbreaks. This study highlights its significance in combating pathogenic outbreaks and focused on the development of multi-valent mRNA vaccines targeting the monkeypox virus. These findings offer valuable insights into the protective mechanisms of multi-valent mRNA vaccines and lay the ground work for future development of effective and safe mRNA vaccines for enhanced protection against monkeypox virus outbreak.
This work was supported by fundings from the National Science and Technology Major Projects, the National Key Research and Development Program of China, the Priority Research Program of Chinese Academy of Sciences, Shanghai Municipal Science and Technology Major Project, and the National Natural Science Foundation of China.
See the article:
Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrated robust immune response and neutralizing activity
https://engine.scichina.com/doi/10.1007/s11427-023-2378-x
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-21
People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes during their pregnancy, especially if they were Black or Hispanic, according to a Mount Sinai study published on June 21 in the journal Diabetes Care.
The study also found that people who experienced gestational diabetes were more than 11 times as likely as those whose pregnancies did not involve gestational diabetes to develop diabetes within nine years after delivery.
The researchers, from the Icahn School of Medicine at Mount Sinai, found that the ...
2023-06-21
Probiotics can help maintain a healthy gut microbiome or restore populations of “good bacteria” after a heavy course of antibiotics. But now, they could also be used as an effective treatment strategy for certain intestinal diseases, such as Crohn’s disease. Researchers reporting in ACS Central Science have developed a microgel delivery system for probiotics that keeps “good” bacteria safe while actively clearing out “bad” ones. In mice, the system treated intestinal inflammation without side effects.
In the digestive system, there’s a delicate balance of bacterial populations. ...
2023-06-21
FAIRFIELD, NJ—Parker Laboratories Inc., a worldwide leader in ultrasound supplies and accessories, has announced the US Food and Drug Administration (FDA) has granted clearance for a unique disinfecting foam, called Tristel ULT, as a high-level disinfectant for ultrasound probes used within body cavities and for skin-surface transducers.
Tristel ULT is manufactured and distributed for US markets by Parker Laboratories under an exclusive commercial partnership with UK-based Tristel plc (AIM: TSTL). Tristel ULT is a high-level disinfectant using a proprietary ...
2023-06-21
Nearly a decade ago, researchers from Brigham Young University, Utah State University and Rutgers published a disheartening study revealing how discrimination in bank loan services was tainting the American Dream for minority entrepreneurs.
Unfortunately, even in 2023, not much has changed. A newly published paper from this core group of authors finds banks still offer Black customers inferior loan products and service, even when those Black customers have objectively stronger financial profiles and FICO ...
2023-06-21
EL PASO, Texas (June 21, 2023) — In 2021, agricultural activities contributed to 10 percent of greenhouse gas emissions in the U.S. Now, researchers at The University of Texas at El Paso will help reduce these emissions by training farmers across the nation on climate-friendly agricultural practices.
The project is supported by a new $2 million, four-year grant from the U.S. Department of Agriculture (USDA).
The team behind the Carbon SMART (Soil Monitoring, Assessment, Research and Training) project includes soil scientists and geochemists from UTEP as well as geomorphologists, landscape ecologists, sociologists, and environmental anthropologists from ...
2023-06-21
Citrus cultivation holds significant importance in Japan and has recently attracted both domestic and global attention. With an agricultural production value of approximately 201 billion yen, citrus is the third most important agricultural product in Japan. The success of the Japanese citrus industry is attributed to the development of new cultivars that are free of pests and diseases, climate-resilient, and exhibit superior fruit quality. Notable examples include 'Asumi', 'Asuki', 'Ehimekashidai28go', 'Ehimekashidai48go', 'Himekoharu', 'Kanpei', 'Rinoka', and 'Mihaya', all of which display improved agricultural ...
2023-06-21
Alexandria, VA, USA – A study seeking to understand the perspectives of decision-makers (DMs) working within health fields in First Nations (FNs) communities in Canada regarding the use of Silver Diamine Fluoride (SDF) as an early childhood caries (ECC) management strategy will be presented at the 101st General Session of the IADR, which will be held in conjunction with the 9th Meeting of the Latin American Region and the 12th World Congress on Preventive Dentistry on June 21-24, 2023, in Bogotá, ...
2023-06-21
IOP Publishing (IOPP) is rolling-out a new co-review policy across its entire owned journal portfolio as part of its commitment to ensuring an inclusive and supportive review process.
Early career researchers (ECRs) often support more experienced academics by contributing ideas or comments to peer review reports. Yet, according to a survey, 70% of ECRs say that their name was withheld from the editorial staff after they served as a reviewer or co-reviewer on a report, and they received no official recognition for their work.
IOPP’s ...
2023-06-21
New research published in the Journal of Internal Medicine demonstrates that optogenetics—which uses light-sensitive proteins to control the activity of targeted cells—is a promising shock-free approach to treating atrial fibrillation (AF), or an irregular, often rapid heart rate, for immediate restoration of regular rhythm.
Current treatments for AF—including medications and shocks to restore a regular heart rhythm—come with low success rates and/or serious side effects. ...
2023-06-21
An analysis of published studies suggests that humor therapy may lessen symptoms of depression and anxiety.
For the analysis, which is published in Brain and Behavior, investigators identified 29 relevant studies that included a total of 2,964 participants and were conducted in nine different countries. Participants had depression or anxiety and included children undergoing surgery or anesthesia; older people in nursing homes; patients with Parkinson's disease, cancer, mental illness, or receiving dialysis; retired women; and college ...
LAST 30 PRESS RELEASES:
[Press-News.org] Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens for enhanced protection
